Susan Hasty, Publisher
Table of Contents . . . July 12th, 1999Non-Subscriber - Summaries Only
Conference Coverage (ASCO) - Ad5CMV-p53 Has Antitumor Effect in Head and Neck Cancer
Gene Transfer - Cationic Lipids Enhance Adenoviral Infection
Neurological Gene Therapy - Animal Model For Canavan Disease Being Developed
Stroke Gene Therapy - Bcl-2 Transduction Protects Neurons From Ischemia
WAS Gene Therapy - Gene Therapy Options for Wiskott-Aldrich Syndrome
Gene Delivery - ODN Transfection into Cardiovascular Tissues
Vaccine Development - New Tool ID's CD4+ T-Cell Antigens
Diabetic Incontinence (Animal Models) - Gene Therapy Could Treat Diabetic Incontinence
Industry News (Patents and Technology) - Patents Issued for Technologies that Destroy Cancer Tumors
Angiogenesis Gene Therapy - "Transfection with Vascular Endothelial Growth Factor Isoform 121 (VEGF121) Enhances Tumorigenicity of Human Transitional Cell Carcinoma (TCC) Growing Orthotopically in the Bladder of Athymic Nude Mic
Angiogenesis Gene Therapy - "Intralesional Interferon Gene Transfer Inhibits the Growth of Human Transitional Cell Carcinoma (TCC) Growing in Athymic Nude Mice by Inhibition of Angiogenesis and Activation of Macrophages."
Vector Development - "Novel Lentiviral Vectors for Gene Therapy with Reduced Pathogenic Potential."
HIV Gene Therapy - "Suppression of HIV-1 Transcription and Replication by a Vpr Mutant."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.